Bariederm Cream in Chronic Contact Dermatitis
1 other identifier
interventional
30
1 country
1
Brief Summary
We intend to evaluate the efficiency and tolerability of a barrier cream (bariederm) in protecting hands of individuals with hand dermatitis, either due to allergy or irritation. We believe that the use of the cream would benefit with the skin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2013
CompletedFirst Posted
Study publicly available on registry
January 3, 2014
CompletedStudy Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedJanuary 3, 2014
January 1, 2014
10 months
December 22, 2013
January 2, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
self evaluation of effectiveness and tolerance in a 1-10 scale
effectiveness tolerance and acceptability in adults with hand dermatitis, evaluated by a self reported and a physician reported questionaires, using a 1-10 scale for evaluation.
21 days
Study Arms (1)
bariederm, barrier cream
EXPERIMENTALone arm study: use of bariederm cream on hands twice daily for 21 days
Interventions
patients are asked to apply twice a day a barrier cream on their hands for 3 weeks only
Eligibility Criteria
You may qualify if:
- patients with dermatitis of the hands
You may not qualify if:
- pregnant ladies,
- known allergy to ingredients -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
: Hadassah Medical Organization, Jerusalem, Israel
Jerusalem, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liran Horev Yakir, MD
Dept of Dermatology, Hadassah Medical Center, Jerusalem 911201, Israel
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DR
Study Record Dates
First Submitted
December 22, 2013
First Posted
January 3, 2014
Study Start
February 1, 2014
Primary Completion
December 1, 2014
Study Completion
March 1, 2015
Last Updated
January 3, 2014
Record last verified: 2014-01